发明申请
- 专利标题： Controlled Release Formulations
- 专利标题（中）： 控释制剂
-
申请号： US13688116申请日： 2012-11-28
-
公开(公告)号： US20130089595A1公开(公告)日： 2013-04-11
- 发明人: Edward T. Maggio , Elias Meezan , Dennis J. Pillion , Sarah L. Morgan , Joe Baggott
- 申请人： Aegis Therapeutics, LLC , The UAB Research Foundation
- 申请人地址： US AL Birmingham US CA San Diego
- 专利权人： THE UAB RESEARCH FOUNDATION,AEGIS THERAPEUTICS, LLC
- 当前专利权人： THE UAB RESEARCH FOUNDATION,AEGIS THERAPEUTICS, LLC
- 当前专利权人地址： US AL Birmingham US CA San Diego
- 主分类号： A61K47/36
- IPC分类号： A61K47/36
摘要：
The present invention provides stable, self-assembling, biocompatible and biodegradable hydrogel formulations, into which one or more compounds may be incorporated allowing for delayed release or controlled release of the incorporated compounds as the hydrogel is degraded in the body.
公开/授权文献
- US08470370B2 Controlled release formulations 公开/授权日：2013-06-25
信息查询
